Literature DB >> 1527520

The neostriatal mosaic: multiple levels of compartmental organization.

C R Gerfen1.   

Abstract

Although schizophrenia may result from dysfunction of the cerebral cortex the possible indirect involvement of the basal ganglia may be important as this neural system provides a major neural system through which the cortex affects behavior. Processing of cortical input occurs within the striatum, which is the main component of the basal ganglia, where excitatory cortical input is transformed to oppositely modulate the output nuclei of the basal ganglia. The details of this transformation, as well as the role of dopamine in this process, are beginning to unfold. Striatal projections to the globus pallidus, through connections with the subthalamic nucleus, modulate excitatory input to the output neurons of the basal ganglia, GABAergic neurons in the internal segment of the globus pallidus and in the substantia nigra, whereas striatal projections directly to these neurons, provide inhibitory inputs. Thus, cortically driven activity in these two striatal output pathways oppositely modulate the output neurons of the basal ganglia. Dopamine appears to play a crucial role in this transformation. D1 and D2 dopamine receptors are specifically expressed by striatonigral and striatopallidal neurons, respectively. The direct action of dopamine through these receptors appears to oppositely modulate the responsiveness of striatal output pathways to cortical input. Insights into the role of dopaminergic function within the basal ganglia may have direct relevance to the development of treatments for schizophrenia.

Entities:  

Mesh:

Year:  1992        PMID: 1527520     DOI: 10.1007/978-3-7091-9211-5_4

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  21 in total

1.  I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.

Authors:  Henrike Neuhoff; Axel Neu; Birgit Liss; Jochen Roeper
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

2.  PET evidence for a role for striatal dopamine in the attentional blink: functional implications.

Authors:  Heleen A Slagter; Rachel Tomer; Bradley T Christian; Andrew S Fox; Lorenza S Colzato; Carlye R King; Dhanabalan Murali; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2012-06-04       Impact factor: 3.225

Review 3.  A possible mechanism for the dopamine-evoked synergistic disinhibition of thalamic neurons via the "direct" and "indirect" pathways in the basal ganglia.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

4.  Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.

Authors:  Torsten Falk; Shiling Zhang; Emilie L Erbe; Scott J Sherman
Journal:  J Comp Neurol       Date:  2006-01-10       Impact factor: 3.215

5.  Independent circuits in the basal ganglia for the evaluation and selection of actions.

Authors:  Marcus Stephenson-Jones; Andreas A Kardamakis; Brita Robertson; Sten Grillner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

Review 6.  Striatal action-learning based on dopamine concentration.

Authors:  Genela Morris; Robert Schmidt; Hagai Bergman
Journal:  Exp Brain Res       Date:  2009-11-11       Impact factor: 1.972

7.  Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.

Authors:  Daniella Rylander; Vincenza Bagetta; Valentina Pendolino; Elisa Zianni; Shane Grealish; Fabrizio Gardoni; Monica Di Luca; Paolo Calabresi; M Angela Cenci; Barbara Picconi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

Review 8.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

9.  Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.

Authors:  X Zhang; Z-J Feng; K Chergui
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 10.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.